Aromatase inhibitors: development and current perspectives (Record no. 17348)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220829092830.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220829b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 17634 |
| Author | Sayyad, Nusrat B. |
| 245 ## - TITLE STATEMENT | |
| Title | Aromatase inhibitors: development and current perspectives |
| 250 ## - EDITION STATEMENT | |
| Volume, Issue number | Vol.56(2), Apr-June |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Karnataka |
| Name of publisher, distributor, etc. | Association of Pharmaceutical Teachers of India (APTI) |
| Year | 2022 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Pagination | 311-320p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Aim: Breast cancer is one of the most common cancers among women, consistently<br/>elevated estrogen level in the blood associated with persistently in breast cancer found in<br/>many studies. The mechanisms of carcinogenesis whereby cancer is associated involved<br/>in the conversion of androgen to estrogen in the presence of enzyme aromatase. Materials<br/>and Methods: Aromatase is a (CYP19), a cytochrome P450, which is the enzyme that<br/>synthesizes estrogen. Aromatase which is expressed in higher concentration in breast<br/>play a pivotal role in the origin and progression of breast cancer.<br/>In situ inhibition of<br/>aromatase enzyme accomplished by the prevention of aromatase expression in breast<br/>cancer. Results: The success of aromatase inhibition could result in the suppression and<br/>progression of breast cancer. One of the ways to reduce the incidence of breast cancer by<br/>inhibiting estrogen biosynthesis in breast tissue. Aromatase inhibitor therapy is considered<br/>for second-line treatment in patients who fail anti-estrogen therapy. Conclusion: Several<br/>potent and selective aromatase inhibitors have been developed and used to treat breast<br/>cancer. Some of them have passed clinical trial phase II. Development in the field has<br/>encouraged us to review work on the Aromatase inhibitor. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4639 |
| Topical term or geographic name entry element | PHARMACEUTICS |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 17635 |
| Co-Author | Sabale, Prafulla M. |
| 773 0# - HOST ITEM ENTRY | |
| Place, publisher, and date of publication | Bengluru Association of Pharmaceutical Teachers of India (APTI) |
| International Standard Serial Number | 0019-5464 |
| Title | Indian journal of pharmaceutical education and research |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| URL | https://www.ijper.org/sites/default/files/IndJPhaEdRes-56-2-311.pdf |
| Link text | Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | School of Pharmacy | School of Pharmacy | Archieval Section | 29/08/2022 | 2022-1415 | 29/08/2022 | 29/08/2022 | Articles Abstract Database |